Home›Stock Screener›Biofil Chemicals›Financial Statements

Biofil Chemicals Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Biofil Chemicals (BIOFILCHEM) reported revenue ₹28 Cr, net profit ₹3 Cr and EPS ₹1.71, with a net profit margin of 10.7% and ROE of 15.8%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Also explore BIOFILCHEM price movement history to track price trends across different timeframes.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 10.71% 2026 data
EBITDA Margin 3.57% 2026 data
Operating Margin 2.00% 2026 data
Return on Assets 5.88% 2026 data
Return on Equity 15.79% 2026 data

Balance Sheet Ratios

Equity Ratio 37.25% 2026 data
Asset Turnover 0.55 2026 data

BIOFILCHEM Revenue, Net Profit & EBITDA — Year-on-Year Growth

BIOFILCHEM YoY (March 2025 vs March 2026) — revenue -17.6%, net profit +200.0%, expenses -15.2%. Analyse Biofil Chemicals ownership structure to track promoter, FII and institutional holdings.

Revenue Growth
-17.6%
Year-over-Year
Net Profit Growth
+200.0%
Year-over-Year
Expense Growth
-15.2%
Year-over-Year
Assets Growth
+8.5%
Year-over-Year
Equity Growth
+5.6%
Year-over-Year
Operating Cash Flow Growth
-200.0%
Year-over-Year

BIOFILCHEM Income Statement — Revenue, EBITDA & Net Profit

Biofil Chemicals revenue ₹28 Cr, EBITDA ₹1 Cr, net profit ₹3 Cr, EPS ₹1.71 (2026) — net profit margin 10.7%. For live price, earnings ratios and company overview, see BIOFILCHEM screener.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 28 34 41 30 23 37 30 23 13 14 14 6
Expenses 28 33 39 29 21 34 28 22 11 11 12 5
EBITDA 1 1 1 1 2 2 2 1 1 3 1 1
Operating Profit Margin % 2.00% 3.00% 2.00% 4.00% 6.00% 4.00% 6.00% 4.00% 8.00% 19.00% 7.00% 13.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 3 1 1 1 1 2 2 1 1 2 1 1
Tax 0 0 0 0 0 1 0 0 0 1 0 0
Net Profit 3 1 1 1 1 1 1 1 1 2 1 1
Earnings Per Share (₹) 1.71 0.34 0.44 0.34 0.44 0.77 0.74 0.30 0.29 1.10 0.48 0.36

BIOFILCHEM Balance Sheet — Assets, Liabilities & Shareholders' Equity

BIOFILCHEM total assets ₹51 Cr, total equity ₹19 Cr, total liabilities ₹ Cr (2025) — ROE 15.8%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 51 47 31 19 33 42 24 24 22 24 14
Current Assets 43 38 22 9 24 32 14 15 13 15 5
Fixed Assets 8 9 9 9 10 10 10 9 9 9 9
Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0
Other Assets 43 39 22 9 24 32 14 15 13 15 5
LIABILITIES
Total Liabilities
Current Liabilities 0 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 19 18 17 17 16 15 14 13 13 11 8
Share Capital 16 16 16 16 16 16 16 16 16 16 16
Reserves & Surplus 3 2 1 1 0 -1 -3 -3 -4 -5 -8

BIOFILCHEM Cash Flow Statement — Operating, Investing & Financing

Biofil Chemicals operating cash flow ₹-2 Cr, investing ₹0 Cr, financing ₹0 Cr, net cash flow ₹-2 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -2 2 0 0 1 1 1 1 1 0 0
Investing Activities 0 0 0 0 0 0 -1 0 -1 0 0
Financing Activities 0 0 0 0 -1 -1 0 0 0 0 0
Net Cash Flow -2 2 0 0 0 0 0 0 0 0 0